Anti-tumour necrosis factor alpha monoclonal antibody - LivzonAlternative Names: Anti-TNFα monoclonal antibody - Livzon
Latest Information Update: 07 Apr 2016
At a glance
- Originator Livzon Group
- Class Monoclonal antibodies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Autoimmune disorders